Internal Medicine, Cardiovascular Disease · Sterling Hgts, MI
NPI
1134122245
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
39242 Dequindre Rd, Suite103
Sterling Hgts, MI, 48310
Phone (586) 795-3600
Groups this clinician bills Medicare through
Medicare paid, 2024
$247K
3,498 services
Medicare patients, 2024
521
Average age 76
Drug cost, 2024
$1.2M
6,146 prescriptions
Company payments, 2025
$642
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael I Dangovian was code 99214 (office e&m - established), 1,072 times for 444 patients. In total Michael I Dangovian billed 3,498 services in 44 codes, and Medicare paid $247K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-01-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,072 | 444 | $90.62 | $97K |
| 93000 Electrocardiogram | Office | 582 | 415 | $10.07 | $5,861 |
| 99232 Hospital E&M - Subsequent | Facility | 206 | 61 | $62.46 | $13K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 175 | 45 | $5.60 | $980 |
| 93306 Echocardiography (TTE/TEE) | Office | 158 | 155 | $146.59 | $23K |
| 99213 Office E&M - Established | Office | 99 | 86 | $65.72 | $6,506 |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 96 | 48 | $85.80 | $8,237 |
| 93296 External Electrocardiographic Monitoring | Office | 88 | 31 | $14.85 | $1,307 |
| 99223 Hospital E&M - Initial | Facility | 85 | 74 | $136.38 | $12K |
| 99204 Office E&M - New | Office | 78 | 78 | $111.88 | $8,727 |
| 93294 External Electrocardiographic Monitoring | Office | 77 | 26 | $20.35 | $1,567 |
| 99231 Hospital E&M - Subsequent | Facility | 71 | 32 | $39.94 | $2,835 |
| 93297 External Electrocardiographic Monitoring | Office | 69 | 11 | $43.88 | $3,028 |
| 93015 Electrocardiogram | Office | 52 | 51 | $49.22 | $2,559 |
| 78452 Myocardial Perfusion Scan | Office | 48 | 48 | $326.21 | $16K |
By year: 2022 $233K for 3,162 services; 2023 $279K for 3,798 services; 2024 $247K for 3,498 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 20 | 18 | $2.96 | $59.28 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael I Dangovian prescribed most often to Medicare patients was Rosuvastatin Calcium, with 543 prescriptions and refills. In total Michael I Dangovian wrote 6,146 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 543 | 1,425 | 171 | $8,704 |
| Telmisartan Generic | 432 | 1,121 | 130 | $20K |
| Amlodipine Besylate Generic | 429 | 1,106 | 130 | $2,877 |
| Carvedilol Generic | 395 | 1,052 | 99 | $5,966 |
| Metoprolol Tartrate Generic | 382 | 946 | 147 | $3,162 |
| Eliquis Apixaban | 360 | 847 | 101 | $468K |
| Ezetimibe Generic | 343 | 895 | 112 | $7,415 |
| Losartan Potassium Generic | 317 | 899 | 101 | $4,937 |
| Atorvastatin Calcium Generic | 269 | 779 | 84 | $4,815 |
| Metoprolol Succinate Generic | 207 | 576 | 67 | $3,963 |
| Lisinopril Generic | 174 | 481 | 48 | $1,309 |
| Furosemide Generic | 163 | 453 | 61 | $1,050 |
| Nebivolol Hcl Generic | 160 | 441 | 48 | $9,798 |
| Entresto Sacubitril/Valsartan | 133 | 321 | 39 | $201K |
| Xarelto Rivaroxaban | 128 | 328 | 35 | $174K |
Brand drugs: 914 claims; generic drugs: 5,232 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael I Dangovian $642 ($642 in general payments such as food, travel and fees) from 13 companies. The largest payer was Medtronic, Inc. with $155.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 3 | $155 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $122 |
| Merck Sharp & Dohme LLC MRK | 4 | $95.19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $69.99 |
| Amgen Inc. AMGN | 3 | $49.51 |
| Pfizer Inc. PFE | 1 | $27.52 |
| Boston Scientific Corporation BSX | 1 | $23 |
| Esperion Therapeutics, Inc. ESPR | 1 | $19.39 |
| CashFlow Solutions, LLC | 1 | $18.8 |
| Scpharmaceuticals Inc. SCPH | 1 | $17.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.